RAP80/UIMC1 as cancer-associated antigen: Alternative splice variants and their immunogenicity

Yuriy V. Shebzukhov, Ekaterina P. Koroleva, Svetlana V. Khlgatian, Pavel V. Belousov, Alexey Y. Sazykin, Tatiana S. Kadachigova, Ekaterina A. Pomerantseva, Maria A. Lagarkova, Sergei A. Nedospasov, Dmitry V. Kuprash

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We have identified RAP80/UIMC1, the protein highly expressed in testis, as a new cancer-associated antigen. Sera from 5% to 10% of patients with different types of cancer contain specific antibodies to RAP80/UIMC1. In order to investigate the possible reasons for RAP80/UIMC1 immunogenicity, we characterized its numerous splice isoforms and mapped immunogenic regions of the protein. The majority of RAP80/UIMC1 transcripts was detected both in normal tissues and in colon tumors. There are several RAP80/UIMC1 isoforms that are predominantly expressed in testis, however we did not observe elevated expression of these transcripts in tumors from seropositive patients. We mapped the major immunogenic region of RAP80/UIMC1 to the central part of the protein encoded by exon 9 which is present in a number of ubiquitous splice forms. Thus, based on our data, autoreactivity to RAP80/UIMC1 is related to reasons other than overexpression or tumor-specific splicing.

Original languageEnglish (US)
Pages (from-to)255-262
Number of pages8
JournalCancer Letters
Volume255
Issue number2
DOIs
StatePublished - Oct 8 2007
Externally publishedYes

Keywords

  • Colon cancer
  • SEREX
  • Transcription

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'RAP80/UIMC1 as cancer-associated antigen: Alternative splice variants and their immunogenicity'. Together they form a unique fingerprint.

Cite this